CBD Halts Aggressive Breast Cancer in Clinical Trials

Dr. Sean McAllister and his colleagues at the California Pacific Medical Center Research Institute have discovered that CBD (cannabidiol) appears to be a very potent inhibitor of agressive and metastisized breast cancer [PDF].

Additionally, they have reported findings on the cumulative effect of CBD in blocking proliferation of brain-cancer cells: http://www.ncbi.nlm.nih.gov/pubmed/20053780, and on CBD’s mechanism of action in blocking breast-cancer metastasis: http://www.ncbi.nlm.nih.gov/pubmed/18025276.

Here’s more from Dr. McAllister:

  • We targeted breast cancer cells that expressed high amounts of the protein Id-1. CBD is highly effective at turning off this specific gene that controls breast cancer metastasis. In addition to directly controlling cancer metastasis, turning off Id-1 has also lead to enhanced activity of first-line agents in preclinical models of cancer.

Dr. McAllister is continuing his groundbreaking research on CBD and cancer at CPMCRI. Information on clinical trials being conducted may be found here.

Website: http://www.cpmc.org

Further research: New Study Finds Cannabis Compound Could Have Even Greater Reach in Inhibiting Aggressive Cancer than Previously Thought: http://www.cpmc.org/about/press/news2012/cannabis-brain.html

Post by Jeffrey Stamberger

Jeffrey writes media content covering the latest in news, medical research, policy changes, and product education from the cannabis industry.
View More